Skip to main content
Medical information Clinical review pending

Autoimmune Testing

Immune Complex Detection by C1q Binding Test

The Immune Complex Detection by C1q Binding Test helps identify immune complexes in the serum, aiding in the diagnosis and management of autoimmune disorders. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL minimum) serum collected in a Red Top tube (No Additive).
Results
Reports are typically available 2-3 weeks after sample submission. Samples must be submitted by the 7th of the month. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Confirm with the laboratory before booking.
Test priceKSh 26,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immune Complex Detection by C1q Binding Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Evaluation of symptoms suggestive of autoimmune disease (e.g., joint pain, fatigue, skin rashes).
  • ✓Monitoring disease activity in known autoimmune conditions.
  • ✓Assisting in the diagnosis of systemic lupus erythematosus (SLE).
  • ✓Investigating unexplained inflammation or organ dysfunction.
  • ✓Patients with a family history of autoimmune disorders.
02

In plain language

What this test helps you understand

This test aids in the evaluation of potential autoimmune disorders by detecting the presence of immune complexes in the serum. It can help guide diagnosis and management strategies.
The Immune Complex Detection by C1q Binding Test is a diagnostic tool used to evaluate the presence of immune complexes in the serum. Immune complexes can be associated with autoimmune disorders, where the immune system mistakenly attacks the body's own tissues. This test helps physicians identify and manage these conditions. It measures the binding of immune complexes to the C1q protein, a component of the immune system. Elevated levels may suggest an autoimmune process. This test is valuable for individuals experiencing symptoms potentially related to autoimmune diseases or those with a family history of such conditions. Early detection can lead to timely intervention and better management of symptoms and disease progression. Discuss your results with your healthcare provider to understand their implications and determine appropriate next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Confirm with the laboratory before booking.
Sample2 mL (1 mL minimum) serum collected in a Red Top tube (No Additive).
MethodologyThe test measures the binding of immune complexes to the C1q protein. Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of immune complexes but does not identify the specific autoimmune disease. Results must be interpreted alongside clinical findings and other laboratory tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immune complexes are clusters of antibodies and antigens that form in the bloodstream. In certain conditions, they can deposit in tissues and cause inflammation.
C1q is a protein involved in the immune system's complement pathway. Binding of immune complexes to C1q suggests the presence of these complexes in the serum.
No, this test indicates the presence of immune complexes, which can be associated with various autoimmune conditions. It aids in the diagnostic process but is not specific to one disease.
Generally, no specific preparation is needed. However, it's always best to confirm any specific instructions with your doctor or the laboratory.
Results should be interpreted by a healthcare professional in conjunction with your medical history, symptoms, and other test results.
Yes, home sample collection services are available for your convenience. Please contact the laboratory to arrange this.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp